Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

News

      Fresenius Medical Care achieves improved health outcomes and savings in Demonstration Program in the United States

      Americas
      Fresenius Medical Care, the world’s largest provider of dialysis products and services, announced the results from the first performance year from its End Stage...

      Intercept Pharmaceuticals Appoints Christian Weyer as Executive Vice President of Research & Development

      Americas
      Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced...

      Novartis’ Ultibro® Breezhaler® significantly improved COPD patients’ lung function after direct switch from Seretide®

      Europe
      Novartis announced positive results from the FLASH study examining the safety and efficacy of directly switching chronic obstructive pulmonary disease (COPD) patients from Seretide®(salmeterol/fluticasone)...

      GSK Submits Landmark IMPACT Data To US Regulatory Authority To Support Expanded Label For Trelegy Ellipta

      Europe
      GlaxoSmithKline plc and Innoviva, Inc. announced the filing of a supplemental New Drug Application (sNDA) with the US Food and Drug Administration (FDA) for...

      Systech International And NKP Pharma Expand Presence In India

      Asia
      Systech International, a global technology leader in serialization, product safety, and consumer and brand protection, and NKP Pharma, an innovator in the field of...

      Characterization of T Cell Subsets in Adult Minimal Change Disease

      Asia
      Minimal change disease (MCD) is a kidney disease characterized by pathology in the glomeruli. The disease has its name because changes associated with it...

      Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda in Europe

      News
      Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada; hereinafter “Sumitomo Dainippon Pharma”) and Angelini S.p.A. announced that the companies have...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.